» Articles » PMID: 34595296

Formalin Murine Model of Pain

Overview
Journal Bio Protoc
Specialty Biology
Date 2021 Oct 1
PMID 34595296
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Pain research is mostly based on experimental assays that use animal models, which may allow deciphering the physiopathology of this condition and to propel drug discovery. The formalin nociception test is considered one of the most predictive approaches to study acute pain in rodents. This test permits monitoring pain-related responses (., itch) caused by a subcutaneous injection of an inflammatory agent, namely 2.5% formalin solution, in the hind paw. After the injection, two distinct time periods or phases of licking/biting behaviour occur, which are separated by a quiescent period. Importantly, these phases differ in duration and underlying mechanisms. Hence, the initial acute phase (phase I), commonly recorded for 5 min just after formalin administration, reflects acute peripheral pain, probably due to direct activation of nociceptors through TRPA1 channels. On the other hand, the phase II, which starts after the quiescent period (5-15 min) and is commonly recorded for 15-30 min, is due to the ongoing inflammatory input and central nociceptive sensitization. Here, we describe in detail the protocol used to perform a reliable and reproducible formalin test in mice.

Citing Articles

Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings.

Asiri Y, Moni S, Ramar M, Chidambaram K Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598351 PMC: 11597627. DOI: 10.3390/ph17111439.


Effects of dimethyl itaconate on expressions of NGFI-A and NGFI-B and inflammatory cytokines in the spinal cord in the formalin test.

Rahimi K, Abbaszadeh M, Bakhtazad S, Ghotbeddin Z Brain Commun. 2024; 6(6):fcae397.

PMID: 39568551 PMC: 11577613. DOI: 10.1093/braincomms/fcae397.


General anesthesia activates a central anxiolytic center in the BNST.

Lu D, Uldry Lavergne C, Choi S, Park J, Kim J, Zhao S Cell Rep. 2024; 43(11):114909.

PMID: 39460938 PMC: 11645888. DOI: 10.1016/j.celrep.2024.114909.


Antinociceptive Behavior, Glutamine/Glutamate, and Neopterin in Early-Stage Streptozotocin-Induced Diabetic Neuropathy in Liraglutide-Treated Mice under a Standard or Enriched Environment.

Gateva P, Hristov M, Ivanova N, Vasileva D, Ivanova A, Sabit Z Int J Mol Sci. 2024; 25(19).

PMID: 39409118 PMC: 11477071. DOI: 10.3390/ijms251910786.


Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates.

Jakubiec M, Abram M, Zagaja M, Socala K, Panic V, Latacz G ACS Chem Neurosci. 2024; 15(17):3228-3256.

PMID: 39166702 PMC: 11378297. DOI: 10.1021/acschemneuro.4c00438.


References
1.
Tjolsen A, Berge O, Hunskaar S, Rosland J, Hole K . The formalin test: an evaluation of the method. Pain. 1992; 51(1):5-17. DOI: 10.1016/0304-3959(92)90003-T. View

2.
Clark J, Gebhart G, Gonder J, Keeling M, Kohn D . Special Report: The 1996 Guide for the Care and Use of Laboratory Animals. ILAR J. 1997; 38(1):41-48. DOI: 10.1093/ilar.38.1.41. View

3.
Mogil J . Animal models of pain: progress and challenges. Nat Rev Neurosci. 2009; 10(4):283-94. DOI: 10.1038/nrn2606. View

4.
Dubuisson D, Dennis S . The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977; 4(2):161-174. DOI: 10.1016/0304-3959(77)90130-0. View

5.
Font J, Lopez-Cano M, Notartomaso S, Scarselli P, Di Pietro P, Bresoli-Obach R . Optical control of pain with a photoactive mGlu receptor negative allosteric modulator. Elife. 2017; 6. PMC: 5388536. DOI: 10.7554/eLife.23545. View